RB1 and neurodegenerative disease: The mechanism of action may be to prevent tau hyperphosphorylation by modulating glycogen synthase kinase 3β and protein phosphatase levels, suggesting that Rb1 is a potential prophylactic drug for AD and other neurodegenerative diseases associated with tau pathology.